AstraZeneca shares rise
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...
AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...
AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
Euronews (English) on MSN17h
AstraZeneca reports strong results boosted by promising trialsAstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of ...
AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...
GlobalData on MSN15h
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trialResearchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were ...
The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback